Acknowledgements
The authors would like to thank Caroline Hellegers for work contributing to results presented in this paper. We also wish to recognize the profoundly important contributions of all the volunteers/participants in our own, and other scientific research projects investigating Alzheimer’s disease.
Financial & competing interests disclosure
P Murali Doraiswamy has received research grant support and/or honoraria for consulting or speaking from several pharmaceutical or diagnostic companies and owns equity in Sonexa Therapeutics. Duke University and P Murali Doraiswamy hold a use patent for an unrelated treatment indication in children; that patent is unlicensed and he derives no income from it. Jeffrey Petrella has received research support from Eisai/Pfizer and AVID Radiopharmaceuticals for pilot studies. Steven Prince and Shoshana Woo have no conflicts to disclose.
The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
No writing assistance was utilized in the production of this manuscript.